Home » Authors » Brady Huggett

Articles by Brady Huggett

Genentech Meets Estimates On Increased Rituxan Revenue

Jan. 17, 2003

By Brady Huggett

Genentech Meets Estimates On Increased Rituxan Revenue

Jan. 17, 2003

By Brady Huggett

Incara Making Sacrifices; Elan Declines Antioxidant Option

Jan. 16, 2003

By Brady Huggett

Incara Making Sacrifices; Elan Declines Antioxidant Option

Jan. 16, 2003

By Brady Huggett

Amylin Files For $141.7M Public Offering From Shelf

Jan. 14, 2003

By Brady Huggett

Amylin Files For $141.7M Public Offering From Shelf

Jan. 14, 2003

By Brady Huggett

ZymoGenetics, Novo Agree On $11M IL-21 Collaboratio

Jan. 10, 2003

By Brady Huggett

ZymoGenetics, Novo Agree On $11M IL-21 Collaboratio

Jan. 10, 2003

By Brady Huggett

Atrix Licenses Japanese Eligard Rights To Sosei In $30M Deal

Jan. 7, 2003

By Brady Huggett

DrugAbuse Sciences' Product Shows Benefit In Phase III Trial

Jan. 7, 2003

By Brady Huggett